CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

NCT01653158 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-Hematologic Malignancies

Interventions

DRUG: CP-751,871
DRUG: Docetaxel

Sponsor

Pfizer